EUVIMEDEUVIMED entdecken
Systematische Übersicht

Abstract 1476: Pretreatment Imaging Biomarkers Predicting Hemorrhagic Transformation After Reperfusion Therapy: A Systematic Review

M. Ali, M. M. Elsayed, A. Elsayed, M. Tolba, S. Labony

Stroke: Vascular and Interventional Neurology · 18.10.2026 · 6 (Suppl_1)

DOI: 10.1161/svi270000_1476 ↗

Kurz gefasst

Systematische Übersicht in der Zeitschrift Stroke: Vascular and Interventional Neurology, erschienen am 18.10.2026. Verfasst von M. Ali und 4 weiteren Autor:innen.

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Introduction/Purpose: Hemorrhagic transformation (HT) and symptomatic intracranial hemorrhage (sICH) remain the most feared complications of reperfusion therapy — intravenous thrombolysis and endovascular thrombectomy (EVT) — in acute ischemic stroke (AIS). Reliable pretreatment imaging biomarkers could refine patient selection, guide monitoring intensity, and support individualized treatment decisions. We performed a systematic review to identify and synthesize the pretreatment imaging predictors most consistently associated with HT/sICH following reperfusion therapy. Materials/Methods: We systematically reviewed published cohort studies, meta-analyses, and post hoc trial analyses evaluating pretreatment imaging biomarkers — noncontrast CT (Alberta Stroke Program Early CT Score [ASPECTS], leukoaraiosis burden), CT/MR perfusion parameters (hypoperfusion intensity ratio [HIR], cerebral blood volume [CBV] index), CT angiography-based collateral scoring, and MRI-based blood-brain barrier (BBB) permeability (mean permeability derangement [MPD])— in relation to HT or sICH after intravenous thrombolysis or EVT. Cerebral microbleed (CMB) burden was also assessed as a candidate biomarker. Reported effect estimates (odds ratios [ORs], adjusted ORs, correlation coefficients, and areas under the curve [AUC]) were extracted and qualitatively synthesized.

Results

Lower baseline ASPECTS was consistently and independently associated with HT/sICH, with each one-point increase reducing adjusted odds of sICH (adjusted OR range ≈0.44-0.71 across cohorts). Poor collateral status on CT angiography showed a strong inverse relationship with sICH (ρ = −0.607, P < .001) and independently predicted sICH (adjusted OR 0.22 for adequate versus poor collaterals). Among perfusion-derived markers, HIR predicted HT after EVT with good discrimination (AUC 0.81) in large-vessel occlusion cohorts, whereas in medium-vessel occlusion strokes a low CBV index, rather than HIR, was the independent predictor (multivariable AUC 0.93). Pretreatment BBB disruption, quantified as MPD on perfusion MRI, was markedly higher in patients who developed parenchymal hematoma than in those who did not (median 13.5% vs 3.6%, P < .0001), with each 5% MPD increase conferring a 20% higher adjusted odds of hemorrhage (OR 1.21, P = .015). Leukoaraiosis on baseline CT was associated with increased post-thrombolysis sICH risk in pooled meta-analytic data (OR 1.55 for any leukoaraiosis; OR 2.53 for severe leukoaraiosis), remaining significant after adjustment (adjusted OR 1.75). By contrast, CMB presence was not independently associated with sICH after EVT (adjusted OR 1.19, P = .73), suggesting CMB burden alone should not preclude reperfusion therapy.

Conclusion

Across the reviewed literature, low ASPECTS, poor collateral status, adverse perfusion profiles (elevated HIR or reduced CBV index), increased blood-brain barrier permeability, and leukoaraiosis emerge as the most consistent pretreatment imaging predictors of hemorrhagic transformation after reperfusion therapy, while cerebral microbleed burden appears to carry comparatively little independent risk. Integrating perfusion- and permeability-based biomarkers with established structural scores may enhance pretreatment hemorrhage risk stratification and inform individualized reperfusion decisions. Prospective, standardized, multicenter validation of a combined imaging risk model is warranted before clinical implementation.

Zitieren

APA

Ali, M., Elsayed, M. M., Elsayed, A., Tolba, M., & Labony, S. (2026). Abstract 1476: Pretreatment Imaging Biomarkers Predicting Hemorrhagic Transformation After Reperfusion Therapy: A Systematic Review. Stroke: Vascular and Interventional Neurology, 6(Suppl_1). https://doi.org/10.1161/svi270000_1476

Vancouver

Ali M, Elsayed MM, Elsayed A, Tolba M, Labony S. Abstract 1476: Pretreatment Imaging Biomarkers Predicting Hemorrhagic Transformation After Reperfusion Therapy: A Systematic Review. Stroke: Vascular and Interventional Neurology. 2026;6(Suppl_1). doi:10.1161/svi270000_1476

BibTeX
@article{Ali2026,
  author = {Ali, M. and Elsayed, M. M. and Elsayed, A. and Tolba, M. and Labony, S.},
  title = {Abstract 1476: Pretreatment Imaging Biomarkers Predicting Hemorrhagic Transformation After Reperfusion Therapy: A Systematic Review},
  journal = {Stroke: Vascular and Interventional Neurology},
  year = {2026},
  volume = {6},
  number = {Suppl_1},
  doi = {10.1161/svi270000_1476}
}
Kostenlos starten →